CDK4/6 Inhibition as a Therapeutic Strategy in Breast Cancer: Palbociclib, Ribociclib, and Abemaciclib

Publication date: Available online 26 March 2018
Source:Seminars in Oncology
Author(s): Bahar Laderian, Tito Fojo




https://ift.tt/2H2qET8